SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-06-010607
Filing Date
2006-02-14
Accepted
2006-02-14 18:39:29
Documents
2
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 6277
2 POA DOCUMENT poa.txt EX-24.5_122386 2854
  Complete submission text file 0001209191-06-010607.txt   10926
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 601 UNION STREET, SUITE 3200 SEATTLE WA 98101
Business Address (206) 621-7200
Naini Nader J (Reporting) CIK: 0001344203 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-24274 | Film No.: 06618849